Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05980923
Other study ID # DCR2023/1.ThyrAcuteIll
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 15, 2023
Est. completion date October 30, 2024

Study information

Verified date December 2023
Source Jordan Collaborating Cardiology Group
Contact Ayman J Hammoudeh, MD, FACC
Phone 0096265001000
Email a.hammoudeh@istisharihospital.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients admitted to the hospital with acute illness may have a wide spectrum of thyroid function abnormalities. It is largely unknown whether such aberrations are temporary or persist for a long time, and whether they impact prognosis of such patients.


Description:

Recently, there has been a growing body of evidence that subclinical thyroid dysfunction as a contributor to the increase of cardiovascular events. Elevated serum thyroid-stimulating hormone (TSH) levels and normal free thyroxine (FT4) and free triiodothyronine (FT3) levels have been associated with worse heart failure and dyslipidemia. Furthermore, higher risk of atrial fibrillation has been linked tp thyroid abnormalities in these patients. Patients admitted to the hospital with acute illness may have a wide spectrum of thyroid function abnormalities. It is largely unknown whether such aberrations are temporary or persist for a long time, and whether they impact prognosis of such patients. This study aimed at evaluating the prevalence of thyroid function abnormalities in patients admitted to hospital with acute illness and their temporal changes and impact on mortality during hospitalization and at 1 year. Serum level of thyroid stimulating hormone and free T4 and T3 measured on admission. Clinical and laboratory profiles of patients with abnormal thyroid function (ATF group) will be compared to those with normal thyroid function (NTF group). Short and long term survival of both groups were compares as well.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date October 30, 2024
Est. primary completion date October 15, 2024
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Hospital admission - Adults aged 18 years and above - Willing to sign an informed consent - Diagnosis on admission is acute illness that includes: heart failure, acute coronary syndrome, sepsis, acute stroke, hypotension, acute system-organ failure including renal and hepatic failure. Exclusion Criteria: - Age less than 18 years. - Refusal to sign consent. - Admission for a reason not classified as acute illness.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Performing blood thyroid test (TSH, FT4, FT3)
Blood test as above

Locations

Country Name City State
Jordan Istishari Hospital Amman

Sponsors (1)

Lead Sponsor Collaborator
Jordan Collaborating Cardiology Group

Country where clinical trial is conducted

Jordan, 

Outcome

Type Measure Description Time frame Safety issue
Primary In hospital mortality All-cause death rate in patients with abnormal thyroid function compared with death in those with no abnormal thyroid function during the patients hospital stay.. From time of study entry until the date of death from any cause, assessed up to 2 weeks.
Secondary 6-month mortality rate All-cause death rate in patients with abnormal thyroid function compared with death in those with no abnormal thyroid function at 6 months. From date of study entry until the date of death from any cause, assessed up to two weeks.
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01682785 - Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder N/A
Completed NCT04470440 - Thyroid Dysfunction and Nivolumab Reponse in NSCLC
Not yet recruiting NCT04809454 - Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt
Recruiting NCT03754621 - Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
Not yet recruiting NCT04323007 - Thyroid Dysfunction in Patients With Nephrotic Syndrome N/A
Completed NCT04013308 - Iontophoresis With Potassium Iodide and Thyroid Function N/A
Completed NCT05385029 - Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19
Not yet recruiting NCT06293534 - Thyroid Dysfunction in Patients With Major Psychiatric Disorders
Terminated NCT03787303 - Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma Phase 2
Completed NCT02832960 - The TRUST Trial - CardioVascular Imaging ECHO Phase 4
Completed NCT02832934 - The TRUST Study - CardioVascular Imaging IMT Phase 4
Completed NCT00592514 - Thyroid Dysfunction in Head and Neck Surgery Patients N/A
Terminated NCT00504218 - Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients
Active, not recruiting NCT04658524 - Evaluation of Thyroid Function in Patients With Chronic Kidney Disease
Completed NCT02500342 - Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism Phase 4
Completed NCT02491008 - Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction Phase 4
Not yet recruiting NCT06185309 - Evaluation of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction
Not yet recruiting NCT04613323 - Management of Thyroid Function in Hashimoto's Thyroiditis During Pregnancy
Recruiting NCT04019509 - The Influence of Different Thyroid Autoantibodies on Thyroid Function and Pregnancy Outcome After Assisted Reproductive Technology N/A
Active, not recruiting NCT04439747 - Develop and Implement Methods for Diagnostic and Treatment of Hormonal Disorders in Patients With Chronic Kidney Disease